Skip to main content
. 2012 Oct 1;7(10):e46562. doi: 10.1371/journal.pone.0046562

Figure 6. Fasting blood glucose (A) and serum insulin (B), leptin (C), adiponectin (D), fasting serum cholesterol (E) and triglycerides (F), liver cholesterol (G) and triglycerides (H) in DIO mice treated with HIF-1α ASO, control ASO or observed untreated.

Figure 6

* and † denote p<0.05 and 0.01, respectively, for the difference with HIF-1α ASO treated mice.